H1B Salary Data

Home › Employers › Calibrate Health, Inc.

Calibrate Health, Inc.: H-1B salaries and sponsorship

Calibrate Health, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $195,000.

Applications (LCAs)3
Certified3
Employer addressNew York, NY
H-1B dependent employerNo
Median offered salary$195,000
Middle half of salaries$162,708–$210,000
10th–90th percentile$143,333–$219,000

Does Calibrate Health, Inc. sponsor H-1B visas?

Calibrate Health, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Nov 22, 2022. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
RX Analyst1$130,416
Senior Software Engineer1$195,000
Engineering Manager1$225,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$162,708
FY20251$225,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
RX Analyst$130,416–$131,000
Level II
Cupertino, CANov 22, 2022Dec 5, 2022Certified, then withdrawn
Senior Software Engineer$195,000–$205,000
Level IV
New York, NYSep 21, 2022Sep 28, 2022Certified, then withdrawn
Engineering Manager$225,000–$250,000
Level IV
Medway, MAOct 15, 2021Nov 1, 2021Certified, then withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).